CRDL
NASDAQ · Pharmaceuticals
Cardiol Therapeutics Inc-A
$1.42
+0.06 (+4.41%)
Open$1.36
Previous Close$1.36
Day High$1.43
Day Low$1.35
52W High$2.33
52W Low$1.23
Volume—
Avg Volume130.2K
Market Cap223.66M
P/E Ratio—
EPS$-0.39
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,609.9% upside
Current
$1.42
$1.42
Target
$24.28
$24.28
$16.80
$24.28 avg
$33.59
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 21.47M | 20.00M | 18.14M |
| Net Income | 5.10M | 5.20M | 4.96M |
| Profit Margin | 23.8% | 26.0% | 27.3% |
| EBITDA | 10.24M | 10.30M | 9.42M |
| Free Cash Flow | 5.58M | 6.38M | 6.16M |
| Rev Growth | +3.9% | -4.2% | -9.3% |
| Debt/Equity | 1.16 | 1.28 | 1.00 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |